97 related articles for article (PubMed ID: 3936372)
1. Inhibitors of factors VIII and IX in a child with Henoch-Schönlein syndrome.
Gouyon JB; Seiller F; Deries X; Alison M; Lorenzini JL; Devilliers E
Am J Pediatr Hematol Oncol; 1985; 7(4):376-7. PubMed ID: 3936372
[No Abstract] [Full Text] [Related]
2. [Behavior of coagulation parameters in the Schönlein-Henoch syndrome. Diagnostic value of factor XIII].
Barberio G; Manganaro R; Ruggeri C; Cambria R; Gattarello A; Gemelli M
Minerva Pediatr; 1981 Aug; 33(16):817-20. PubMed ID: 7311944
[No Abstract] [Full Text] [Related]
3. Combined factor VIII and IX inhibitors in a girl.
Reussi C; Altman R; Rouvier J; Maino R
Thromb Diath Haemorrh; 1966 Dec; 16(3):549-58. PubMed ID: 5996674
[No Abstract] [Full Text] [Related]
4. [Thrombocytosis and reduced levels of factor VIII in rheumatoid purpura in children].
Bost M; Kolodie L; Pouzol P; Dechelette E; Joannard A; Andreani P
Pediatrie; 1986; 41(5):401-11. PubMed ID: 3101037
[TBL] [Abstract][Full Text] [Related]
5. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
[TBL] [Abstract][Full Text] [Related]
6. [The prognostic value of factor XIII in Schönlein-Henoch purpura in childhood (author's transl)].
Dalens B; Bezou MJ; Goumy P; Déméocq F; Menut G
Arch Fr Pediatr; 1980 Feb; 37(2):99-101. PubMed ID: 7396652
[TBL] [Abstract][Full Text] [Related]
7. Lupus anticoagulant and thrombosis following Henoch-Schonlein purpura.
Abend NS; Licht DJ; Spencer CH
Pediatr Neurol; 2007 May; 36(5):345-7. PubMed ID: 17509470
[TBL] [Abstract][Full Text] [Related]
8. Coagulation inhibitors.
Corrigan JJ
Am J Pediatr Hematol Oncol; 1980; 2(3):281-8. PubMed ID: 6776839
[TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with factor VIII and IX inhibitors.
Nilsson IM; Berntorp E; Freiburghaus C
Thromb Haemost; 1993 Jul; 70(1):56-9. PubMed ID: 8236114
[No Abstract] [Full Text] [Related]
10. Could it be Henoch-Schonlein purpura?
Lim DC; Cheng LN; Wong FW
Aust Fam Physician; 2009 May; 38(5):321-4. PubMed ID: 19458803
[TBL] [Abstract][Full Text] [Related]
11. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
Carmassi F; Giannarelli C; De Giorgi A; De Negri F
Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
[TBL] [Abstract][Full Text] [Related]
12. Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura.
Casonato A; Pontara E; Bertomoro A; Ossi E; Vincenti M; Girolami A; Borsatti A; Bertaglia G
Am J Hematol; 1996 Jan; 51(1):7-11. PubMed ID: 8571941
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenesis and correlation of disorders of hemostasis in Schoenlein-Henoch hemorrhagic vasculitis].
Barkagan LZ; Arkhipov BF
Ter Arkh; 1980; 52(9):59-62. PubMed ID: 7434235
[No Abstract] [Full Text] [Related]
14. Laboratory signs of activated coagulation are common in Henoch-Schönlein purpura.
Brendel-Müller K; Hahn A; Schneppenheim R; Santer R
Pediatr Nephrol; 2001 Dec; 16(12):1084-8. PubMed ID: 11793106
[TBL] [Abstract][Full Text] [Related]
15. [Schönlein-Henoch syndrome: review of a series of 142 cases].
García E; Santos F; Suárez MD; Diéguez MA; Málaga S; Crespo M
An Esp Pediatr; 1985 Jun; 22(8):557-63. PubMed ID: 4051340
[TBL] [Abstract][Full Text] [Related]
16. Risk of inhibitor development after intermediate purity coagulation factor concentrates: is it truly low?
Mannucci PM
Thromb Haemost; 1995 Sep; 74(3):997. PubMed ID: 8571341
[No Abstract] [Full Text] [Related]
17. Lupus anticoagulant and IgM anti-phospholipid antibodies in Korean children with Henoch-Schonlein purpura.
Shin JI; Lee JS; Kim HS
Scand J Rheumatol; 2009; 38(1):73-4; author reply 74-5. PubMed ID: 19191188
[No Abstract] [Full Text] [Related]
18. [Immune coagulation disorders (excluding antiphospholipid syndrome].
Arai M
Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
[TBL] [Abstract][Full Text] [Related]
19. [Favorable effects of epsilon-aminocaproic acid on the children with nephrotic syndrome and Schonlein-Henoch syndrome treated with corticosteroids].
Prandota J; Panków-Prandota L; Rotter A; Kotecki L
Pol Merkur Lekarski; 1996 Oct; 1(4):241-5. PubMed ID: 9156934
[TBL] [Abstract][Full Text] [Related]
20. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
Mahasandana C; Patharathienskul D; Suvatte V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
